Direct oral anticoagulants, all-cause mortality and cardiovascular events in patients with atrial fibrillation with and without obesity: a sub-analysis of the nationwide START registry.
Haemorrhagic risk in elderly patients with atrial fibrillation that develop low platelet count during direct oral anticoagulant treatment: insights from the ATHERO-AF study.
Event:
ESC Congress 2024
Topic:
Anticoagulants
Session:
Antithrombotic and anticoagulant therapy in special populations